Live birth from a 46 year old using fresh autologous oocytes through in vitro fertilization

We report a live birth with in vitro fertilization from a 46-year-old woman using autologous oocytes.

Like Comment

Authors

Mark P. Trolice, M.D.

Volume 102, Issue 1, Pages 96–98

Abstract

Objective:

To report a live birth with IVF from a 46-year-old woman using autologous oocytes.

Design:

Case report.

Setting:

Reproductive endocrinology and infertility private practice and ambulatory IVF center.

Patient(s):

One 46-year-old nulligravid woman.

Intervention(s):

IVF with fresh ET.

Main Outcome Measure(s):

Live birth after IVF.

Result(s):

A 46-year-old with antimullerian hormone (AMH) level less than 0.16 conceived through IVF using autologous oocytes. A total of seven oocytes were retrieved, from which four embryos were transferred at the cleavage stage, resulting in a pregnancy and delivery of a healthy male infant weighing 1,580 g at 31 and 3/7 weeks’ estimated gestational age.

Conclusion(s):

The prognosis for a live birth from IVF in a patient with very advanced reproductive age, particularly with an undetectable AMH level using autologous oocytes, remains extremely poor. This case should be interpreted with caution so as to not provide false hope to women aged 45 and above.

Read the full text at: http://www.fertstert.org/article/S0015-0282(14)00360-4/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.